# Jean Kaseya

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/jean-kaseya
Canonical HTML page: https://getbiobrief.com/entity/jean-kaseya

## Timeline

- **2026-08-04**: Leadership Visits and Latest Data Released — Africa CDC Director-General Jean Kaseya visited Bunia, WHO Director-General Tedros arrived in Kinshasa; government update reported 3,802 cases and 1,707 deaths.
- **2026-08-03**: Healthcare Workers Issue Ultimatum — In Mongbwalu, healthcare workers threatened to escalate action within 24 hours if unpaid wages were not resolved.
- **2026-06-15**: Uganda Declared Ebola‑Free — Neighboring Uganda discharged its last Ebola patient, ending its own transmission chain linked to the Congo outbreak.
- **2026-05-15**: Outbreak Declared — Eastern Congo Ebola outbreak officially declared, later linked to Bundibugyo virus.

## Recent coverage (2 stories)

### As Ebola Deaths Top 1,700, Biotech Races for Bundibugyo Virus Treatments
2026-08-04 15:58:13 · Sentiment: Strongly negative · Impact: 8/10 · Sources: 6

Congo’s Bundibugyo Ebola outbreak has surged to 3,802 cases and 1,707 deaths, highlighting an urgent need for vaccines and treatments. With no approved products available, two post‑exposure prophylaxis trials in Ituri and two vaccine trials in the UK and Canada are now underway, while nearly 80% of new cases elude contact tracing.
Full story: https://getbiobrief.com/story/ebola-deaths-top-1700-bundibugyo-virus-trials

### Bundibugyo Ebola outbreak with no approved vaccine tops 782 cases after record spike
2026-06-15 11:52:09 · Sentiment: Strongly negative · Impact: 8/10 · Sources: 2

The rare Bundibugyo Ebola virus has infected 782 people and killed 181 in Congo, with a record 72 new cases in one day. No approved vaccine or treatment exists for this strain, creating an urgent gap for biotech and pharma to address with rapid countermeasure development.
Full story: https://getbiobrief.com/story/bundibugyo-ebola-outbreak-no-vaccine-782-cases

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.